Lucence and Yemaachi Launch the AMBER Study to Detect and Characterize Genomic Alterations in Breast Cancer in Women in Africa and Expand Liquid Biopsy Access
PALO ALTO, Calif. & ACCRA, Ghana–(BUSINESS WIRE)–Lucence, a precision oncology company using liquid biopsy to bring clarity to cancer care, and Yemaachi Biotech, a cancer research company based in Accra, Ghana, announced today that they are collaborating on a study to better characterize and understand the genomics of breast cancer in women of African descent.
This YC Summer batch features the largest group of African startups yet
Tech Crunch profiles Yemaachi Biotech and the other 14 African Startups that were selected to be a part of Y Combinator’s summer batch of 2021.
“The Scientist” Feature: Quest for Research Freedom Fuels African Biotech Boom
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab
H3D Partners with Yemaachi to Utilise African Genetic Diversity to Develop New Tools for Improving Treatment Outcomes for the African Patient Populations
The Holistic Drug Discovery and Development (H3D) Centre at the University of Cape Town (UCT) has entered into a strategic partnership with Yemaachi Biotech, to exploit African genetic diversity by identifying new therapies and platforms that optimize cancer treatments for African patient populations.
Public Engagement on COVID-19 Vaccine Roll Out Plan
Yaw Bediako, PhD joined a distinguished panel of Ghana’s healthcare leaders and government representatives to engage the public on the nation’s COVID-19 vaccine roll out plan. The event, held on 19th February 2021 at Alisa Hotel North Ridge and broadcast live on national television, was hosted by the Minister of Information Designate Hon. Kojo Oppong […]
Unseen and unheard: African children with cancer are consistently excluded from clinical trials
Dr. Ella Amoako, Desmond Jumbam and Dr. Yaw Bediako authored an editorial in the January 2021 edition of BMJ Global Health, discussing the impact that excluding African participants from clinical trials has on childhood cancer research.